Literature DB >> 26895046

Retrotransposon Capture Sequencing (RC-Seq): A Targeted, High-Throughput Approach to Resolve Somatic L1 Retrotransposition in Humans.

Francisco J Sanchez-Luque1,2, Sandra R Richardson1,3, Geoffrey J Faulkner4,5.   

Abstract

Mobile genetic elements (MGEs) are of critical importance in genomics and developmental biology. Polymorphic and somatic MGE insertions have the potential to impact the phenotype of an individual, depending on their genomic locations and functional consequences. However, the identification of polymorphic and somatic insertions among the plethora of copies residing in the genome presents a formidable technical challenge. Whole genome sequencing has the potential to address this problem; however, its efficacy depends on the abundance of cells carrying the new insertion. Robust detection of somatic insertions present in only a subset of cells within a given sample can also be prohibitively expensive due to a requirement for high sequencing depth. Here, we describe retrotransposon capture sequencing (RC-seq), a sequence capture approach in which Illumina libraries are enriched for fragments containing the 5' and 3' termini of specific MGEs. RC-seq allows the detection of known polymorphic insertions present in an individual, as well as the identification of rare or private germline insertions not previously described. Furthermore, RC-seq can be used to detect and characterize somatic insertions, providing a valuable tool to elucidate the extent and characteristics of MGE activity in healthy tissues and in various disease states.

Entities:  

Keywords:  Alu; LINE-1; Mobile genetic element; Neurogenesis; Oncogenesis; Retrotransposition; Somatic mosaicism; Whole genome sequencing (WGS)

Mesh:

Substances:

Year:  2016        PMID: 26895046     DOI: 10.1007/978-1-4939-3372-3_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Human transposon insertion profiling: Analysis, visualization and identification of somatic LINE-1 insertions in ovarian cancer.

Authors:  Zuojian Tang; Jared P Steranka; Sisi Ma; Mark Grivainis; Nemanja Rodić; Cheng Ran Lisa Huang; Ie-Ming Shih; Tian-Li Wang; Jef D Boeke; David Fenyö; Kathleen H Burns
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

2.  Identification of polymorphic SVA retrotransposons using a mobile element scanning method for SVA (ME-Scan-SVA).

Authors:  Hongseok Ha; Jui Wan Loh; Jinchuan Xing
Journal:  Mob DNA       Date:  2016-07-30

Review 3.  Retrotransposon-induced mosaicism in the neural genome.

Authors:  Gabriela O Bodea; Eleanor G Z McKelvey; Geoffrey J Faulkner
Journal:  Open Biol       Date:  2018-07       Impact factor: 6.411

4.  Transposon insertion profiling by sequencing (TIPseq) for mapping LINE-1 insertions in the human genome.

Authors:  Jared P Steranka; Zuojian Tang; Mark Grivainis; Cheng Ran Lisa Huang; Lindsay M Payer; Fernanda O R Rego; Thiago Luiz Araujo Miller; Pedro A F Galante; Sitharam Ramaswami; Adriana Heguy; David Fenyö; Jef D Boeke; Kathleen H Burns
Journal:  Mob DNA       Date:  2019-03-08

5.  Human transposon insertion profiling by sequencing (TIPseq) to map LINE-1 insertions in single cells.

Authors:  Wilson McKerrow; Zuojian Tang; Jared P Steranka; Lindsay M Payer; Jef D Boeke; David Keefe; David Fenyö; Kathleen H Burns; Chunhong Liu
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-02-10       Impact factor: 6.237

Review 6.  Gene editing in the context of an increasingly complex genome.

Authors:  K Blighe; L DeDionisio; K A Christie; B Chawes; S Shareef; T Kakouli-Duarte; C Chao-Shern; V Harding; R S Kelly; L Castellano; J Stebbing; J A Lasky-Su; M A Nesbit; C B T Moore
Journal:  BMC Genomics       Date:  2018-08-08       Impact factor: 3.969

7.  Integrated Mobile Element Scanning (ME-Scan) method for identifying multiple types of polymorphic mobile element insertions.

Authors:  Jui Wan Loh; Hongseok Ha; Timothy Lin; Nawei Sun; Kathleen H Burns; Jinchuan Xing
Journal:  Mob DNA       Date:  2020-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.